Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-024320
Filing Date
2025-11-19
Accepted
2025-11-19 17:13:42
Documents
62
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 2385774
2 EX-31.1 ex31-1.htm EX-31.1 19721
3 EX-31.2 ex31-2.htm EX-31.2 12433
4 EX-32.1 ex32-1.htm EX-32.1 7747
5 EX-32.2 ex32-2.htm EX-32.2 7676
  Complete submission text file 0001493152-25-024320.txt   10149727

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE tnfa-20250930.xsd EX-101.SCH 70276
7 XBRL CALCULATION FILE tnfa-20250930_cal.xml EX-101.CAL 55155
8 XBRL DEFINITION FILE tnfa-20250930_def.xml EX-101.DEF 312679
9 XBRL LABEL FILE tnfa-20250930_lab.xml EX-101.LAB 560877
10 XBRL PRESENTATION FILE tnfa-20250930_pre.xml EX-101.PRE 419606
64 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1724204
Mailing Address 1185 AVENUE OF THE AMERICAS SUITE 249 NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS SUITE 249 NEW YORK NY 10036 856-848-8698
Q/C TECHNOLOGIES, INC. (Filer) CIK: 0001321834 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 251500166
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)